Charles River Laboratories International, Inc.

NYSE:CRL

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

Location

United States

Market Cap

USD 7.72 B

Share Price

USD 157.12

Avg Daily Volume

1,622,587

Change (1 day)

-0.24%

Change (1 year)

-21.99%

Change (YTD)

-14.89%

Charles River Laboratories International, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending March 29, 2025: 32.43%

Charles River Laboratories International, Inc. Gross Profit Margin is 32.43% for the Trailing 12 Months (TTM) ending March 29, 2025, a -9.26% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Charles River Laboratories International, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending March 30, 2024 was 35.75%, a -0.40% change year over year.
Charles River Laboratories International, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending April 01, 2023 was 35.89%, a -4.44% change year over year.
Charles River Laboratories International, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending March 26, 2022 was 37.56%, a 1.11% change year over year.
Charles River Laboratories International, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending March 27, 2021 was 37.15%, a 1.32% change year over year.